Information Provided By: 
Fly News Breaks for January 21, 2020
MDT
Jan 21, 2020 | 20:03 EDT
Piper Sandler analyst Matt O'Brien raised his price target on Medtronic to $135 and kept his Overweight rating after its announcement that the FDA has approved its Micra AV pacemaker. The analyst sees the approval as an "opportunity to materially increase" Micra's total addressable market, adding that Medtronic clearly possesses the superior technology in the pacemaker space and currently has a leg up against the competition.
News For MDT From the Last 2 Days
There are no results for your query MDT
